2m 2m 2m 2m 2m 2m 2m
Spyre Therap (SYRE)
NASDAQ
$90.68+$0.08 (+0.08%)
Price as of Sep 11, 2026 7:30 PM EDT- $8.0BMarket Cap
- 478.91%1-Year Change
- BiotechnologyIndustry
Spyre Therap (SYRE)
$90.68+$0.08 (+0.08%)
SYRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $90.60 | ||
Change | +$1.89 (+2.13%) | ||
Open | $90.00 | ||
High | $91.41 | ||
Low | $87.89 | ||
Previous Close | $88.71 | ||
Volume | 886,055 | ||
30-Day Average Volume | 1,110,648 | ||
1-Week Change | 1.82% | ||
1-Month Change | -11.82% | ||
1-Year Change | 478.91% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.2M | ||
Total Assets | $1.2B | ||
Market Cap | $8.0B | ||
Enterprise Value | $7.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$36.2M | ||
Free Cash Flow | -$69.9M | ||
EBIT | -$36.2M | ||
EBITDA | -$36.2M | ||
Net Working Capital | $1.1B | ||
EPS | -$14.60 | ||
Enterprise Value/EBITDA | -216 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -114 | ||
Price/Operating Cash Flow | -114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/08/2023 | ||
Earnings & Revenue